Literature DB >> 22391547

Development of a robust cytopathic effect-based high-throughput screening assay to identify novel inhibitors of dengue virus.

Kevin D McCormick1, Shufeng Liu, Jana L Jacobs, Ernesto T A Marques, Nicolas Sluis-Cremer, Tianyi Wang.   

Abstract

We have developed a robust cytopathic effect-based high-throughput screening assay to identify inhibitors of dengue virus (DENV) infection. Screening of a small natural product library yielded 11 hits. Four of these were found to be potent inhibitors of DENV, although serotype differences were noted. Taken together, these data suggest that screening of larger and more complex molecule libraries may result in the identification of more potent and specific DENV inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391547      PMCID: PMC3370735          DOI: 10.1128/AAC.06425-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.

Authors:  Jenny Chan; Shakila N Khan; Isabelle Harvey; William Merrick; Jerry Pelletier
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

2.  Trichodermin, a possible inhibitor of the termination process of protein synthesis.

Authors:  M E Stafford; C S McLaughlin
Journal:  J Cell Physiol       Date:  1973-08       Impact factor: 6.384

3.  Comparative studies of the regeneration of HeLa cell receptors for poliovirus T1 and coxsackievirus B3.

Authors:  N H Levitt; R L Crowell
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

4.  Different effects of chloramphenicol, dactinomycin, and streptovitacin A on synthesis of tumor and virion antigens in SV40 virus-infected cells.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1966-05       Impact factor: 11.205

5.  Effects of streptovitacin A on the initial events in the replication of vaccinia and reovirus.

Authors:  S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

6.  A new antitumor antibiotic, bactobolin produced by Pseudomonas.

Authors:  S Kondo; Y Horiuchi; M Hamada; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1979-10       Impact factor: 2.649

Review 7.  Dengue/dengue haemorrhagic fever: history and current status.

Authors:  Duane J Gubler
Journal:  Novartis Found Symp       Date:  2006

8.  Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.

Authors:  I Kubo; H Muroi; M Himejima
Journal:  J Nat Prod       Date:  1993-02       Impact factor: 4.050

9.  Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

Authors:  Michael S Diamond; Marcus Zachariah; Eva Harris
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

10.  Next-generation dengue vaccines: novel strategies currently under development.

Authors:  Anna P Durbin; Stephen S Whitehead
Journal:  Viruses       Date:  2011-09-26       Impact factor: 5.048

View more
  3 in total

1.  Selective degradation of plasmid-derived mRNAs by MCPIP1 RNase.

Authors:  Yisong Qian; Xiuzhen Li; Ruidong Miao; Shufeng Liu; Hong-Bo Xin; Xiaotian Huang; Tony T Wang; Mingui Fu
Journal:  Biochem J       Date:  2019-10-15       Impact factor: 3.857

2.  MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells.

Authors:  Shufeng Liu; Chao Qiu; Ruidong Miao; Jianhua Zhou; Aram Lee; Baoming Liu; Sandra N Lester; Weihui Fu; Lingyan Zhu; Linxia Zhang; Jianqing Xu; Daping Fan; Kui Li; Mingui Fu; Tianyi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

3.  Label-Free Digital Holo-tomographic Microscopy Reveals Virus-Induced Cytopathic Effects in Live Cells.

Authors:  Artur Yakimovich; Robert Witte; Vardan Andriasyan; Fanny Georgi; Urs F Greber
Journal:  mSphere       Date:  2018-11-21       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.